Use of viscoelastic haemostatic assay in emergency and elective surgery

Hong Kong Medical Journal

Volumn 21, Issue 1, 2015, Pages 45-51

  Yeung, Maximus C F ^a   Tong, Steven Y T ^a   Tong, Paul Y W ^a   Cheung, Billy H H ^a   Ng, Joanne Y W ^a   Leung, Gilberto K K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DABIGATRAN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; VISCOELASTIC SUBSTANCE;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CLOT STRENGTH; ELECTIVE SURGERY; EMERGENCY SURGERY; FIBRINOLYSIS; HEART SURGERY; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; LIVER TRANSPLANTATION; PATIENT MONITORING; POINT OF CARE TESTING; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTATIONAL THROMBOELASTOMETRY; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; TRAUMATOLOGY; VISCOELASTIC HAEMOSTATIC ASSAY; BLOOD; DIAGNOSTIC USE; HEMORRHAGIC DISORDERS; PROCEDURES; SURGERY;

ANTICOAGULANTS; ELECTIVE SURGICAL PROCEDURES; HEMORRHAGIC DISORDERS; HEMOSTASIS, SURGICAL; HUMANS; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE; THROMBELASTOGRAPHY; VISCOELASTIC SUBSTANCES;

EID: 84922813443     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj134147     Document Type: Article

References (48)

1. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006;32 Suppl 1:32-8.
2. Wikkelsoe AJ, Afshari A, Wetterslev J, Brok J, Moeller AM. Monitoring patients at risk of massive transfusion with thrombelastography or thromboelastometry: a systematic review. Acta Anaesthesiol Scand 2011;55:1174-89.
3. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366-75.
4. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716-20.
5. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5:289-95.
6. Hartert H. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren [in German]. Klin Wochenschr 1948;26:577-83.
7. Bontempo FA, Lewis JH, Van Thiel DH, et al. The relation of preoperative coagulation findings to diagnosis, blood usage and survival in adult liver transplantation. Transplantation 1985;39:532-6.
8. Steib A, Gengenwin N, Freys G, Boudjema K, Levy S, Otteni JC. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth 1994;73:645-8.
9. Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 1988;71:1090-5.
10. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011;(3):CD007871.
11. Wang SC, Shieh JF, Chang KY, et al. Thromboelastographyguided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010;42:2590-3.
12. Aoki K, Sugimoto A, Nagasawa A, Saito M, Ohzeki H. Optimization of thromboelastography-guided platelet transfusion in cardiovascular surgery. Gen Thorac Cardiovasc Surg 2012;60:411-6.
13. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185-93.
14. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007;13:680-5.
15. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiply injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007;38:298-304.
16. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.
17. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008;65:748-54.
18. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010;252:434-4.
19. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273-82.
20. Sankarankutty A, Nascimento B, Teodoro da Luz L, Rizoli S. TEG and ROTEM in trauma: similar test but different results. World J Emerg Surg 2012;7 Suppl 1:S3.
21. Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011;39:2652-8.
22. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;(1):CD001886.
23. Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013;17:1-79.
24. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011;15:R83.
25. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEMR)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55.
26. Kashuk JL, Moore EE, Le T, et al. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography. J Surg Res 2009;156:133-8.
27. Kashuk JL, Moore EE, Wohlauer M, et al. Initial experiences with point-of-care rapid thrombelastography formanagement of life-threatening postinjury coagulopathy. Transfusion 2012;52:23-33.
28. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 2002;97:837-41.
29. Koster A, Despotis G, Gruendel M, et al. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Anesth Analg 2002;95:26-30.
30. Johansson PI, Solbeck S, Genet G, Stensballe J, Ostrowski SR. Coagulopathy and hemostatic monitoring in cardiac surgery: an update. Scand Cardiovasc J 2012;46:194-202.
31. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990;12:553-8.
32. Lisman T, Porte RJ. Hepatic artery thrombosis after liver transplantation: more than just a surgical complication? Transpl Int 2009;22:162-3.
33. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-7.
34. Widen A, Rolando N, Manousou P, et al. Anticoagulation after liver transplantation: a retrospective audit and casecontrol study. Blood Coagul Fibrinolysis 2009;20:615-8.
35. Cerutti E, Stratta C, Romagnoli R, et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004;10:289-94.
36. Jacob M, Smedira N, Blackstone E, Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. Am J Cardiol 2012;109:824-30.
37. Jacob M, Smedira N, Blackstone E, Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011;123:577-83.
38. Coppell JA, Thalheimer U, Zambruni A, et al. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an invitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 2006;17:97-104.
39. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-40.
40. Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant 2006;25:653-63.
41. Carroll RC, Chavez JJ, Simmons JW, et al. Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time. Anesth Analg 2006;102:1316-9.
42. da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med 2013;21:29.
43. Scarpelini S, Rhind SG, Nascimento B, et al. Normal range values for thromboelastography in healthy adult volunteers. Braz J Med Biol Res 2009;42:1210-7.
44. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007;105:1610-3.
45. Centers for Disease Control and Prevention. Considering the clinical laboratory improvement amendment. CDC website: http://wwwn.cdc.gov/cliac/pdf/Addenda/cliac0210/Addendum%20Y.pdf. Accessed 9 Feb 2010.
46. Lee TH, McCully BH, Underwood SJ, Cotton BA, Cohen MJ, Schreiber MA. Correlation of conventional thrombelastography and rapid thrombelastography in trauma. Am J Surg 2013;205:521-7.
47. Rundgren M, Engstrom M. A thromboelastometric evaluation of the effects of hypothermia on the coagulation system. Anesth Analg 2008;107:1465-8.
48. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and thromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009;17:45.